The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy

BACKGROUND: Deficiency in butyrylcholinesterase (BChE), a condition commonly noticed in liver damage, inflammation, and malnutrition, has previously been associated with impaired prognosis in different malignancies. The aim of the present study was to investigate the value of pretreatment serum BChE...

Descripción completa

Detalles Bibliográficos
Autores principales: Poetsch, Nina, Sturdza, Alina, Aust, Stefanie, Polterauer, Stephan, Grimm, Christoph, Schwameis, Richard, Pötter, Richard, Koelbl, Heinz, Reinthaller, Alexander, Seebacher, Veronika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488555/
https://www.ncbi.nlm.nih.gov/pubmed/30737542
http://dx.doi.org/10.1007/s00066-019-01430-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488555/
https://www.ncbi.nlm.nih.gov/pubmed/30737542
http://dx.doi.org/10.1007/s00066-019-01430-z

Ejemplares similares